Veterinary and Comparative Oncology

Papers
(The H4-Index of Veterinary and Comparative Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Issue Information31
Issue Information31
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy18
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma17
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy17
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours15
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)15
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma15
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours13
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain13
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy13
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping12
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study12
Prognostic Significance of Tumour Infiltrating Lymphocytes in Canine Oral Malignant Melanoma Treated With Anti‐Programmed Cell Death Ligand 1 ( PD ‐ 12
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study12
Dose and Duration of Upfront Steroid Administration Have no Prognostic Impact in Dogs With Multicentric Diffuse Large B‐Cell Lymphoma12
1.1870450973511